Jacqueline Benedetti

Author PubWeight™ 28.81^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?	J Clin Oncol	2004	7.36
2	Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.	J Clin Oncol	2010	4.69
3	Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.	J Clin Oncol	2009	2.66
4	End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.	J Clin Oncol	2007	2.41
5	Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.	Clin Trials	2010	2.24
6	Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.	J Natl Cancer Inst	2013	1.90
7	Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.	Ann Surg Oncol	2002	1.81
8	Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups.	Clin Cancer Res	2011	1.42
9	Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.	J Clin Oncol	2009	1.24
10	Asynchronous communication among clinical researchers: a study for systems design.	Int J Med Inform	2005	1.15
11	Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.	Cancer	2005	1.13
12	Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.	J Clin Oncol	2010	0.99
13	An ethnographic study of collaborative clinical trial protocol writing.	Stud Health Technol Inform	2004	0.92
14	Cancer research training: the Southwest Oncology Group young investigator training program (YITP).	J Cancer Educ	2006	0.75